Follow-Up Letter to FDA Commissioner Hamburg about FDA Advisory Committee Chair Just-Cancelled Participation in Pharmaceutical I

View as PDF.

View the Press Release.

On Oct. 24, 2013, Public Citizen’s Dr. Sidney Wolfe informed Food and Drug Administration (FDA) Commissioner Margaret Hamburg of an FDA advisory committee chair’s planned participation in a pharmaceutical industry conference. The issue received national media attention, and the chairperson, Dr. Lynn Drake, subsequently promised to withdraw from the event. In this follow-up letter to Hamburg, Wolfe highlights conflicting statements made to the press by the FDA, Drake, and the conference organizer. The contradictory nature of the statements illuminates the urgent need for a written policy to address inadequate ethics training of FDA advisory committee members.